Oncology Meeting Resources

European Multidisciplinary Cancer Congress 2011

24 Sep - 27 Sep, Stockholm, Sweden

Access here a selection of webcasts from the 2011 European Multidisciplinary Cancer Congress. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Search Meeting Resources by Keyword

 

 

Useful links

Presenter Presentation title Session title
L. Dirix A Pivotal Multicenter Trial Evaluating Efficacy and Safety of the Hedgehog Pathway Inhibitor (HPI) Vismodegib in Patients With Advanced Basal Cell Carcinoma (BCC) Presidential Session I: Best and Late Breaking Abstracts
D. Zips Stem Cells in Head and Neck Cancer Head and Neck: What Next in Biologically Targeted Therapy?
S. Kopetz Biomarkers & Angiogenesis Anti-Angiogenic Strategies for Cancer
R. Kerbel Differential and Unexpected Impact of Adjuvant Versus Metastatic Antiangiogenic Therapy Anti-Angiogenic Strategies for Cancer
L. Siu Targeted Agents in Salivary Gland Tumours Head and Neck: What Next in Biologically Targeted Therapy?
C. Parker Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA) Presidential Session I: Best and Late Breaking Abstracts
H. Senn ESMO Lifetime Achievement Award European Society for Medical Oncology (ESMO) - Awards Session
J. Tabernero Results From VELOUR, a Phase III Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC) Presidential Session II: Best and Late Breaking Abstracts
C. Aghajanian Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase III Trial of Chemotherapy ± Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC) Presidential Session II: Best and Late Breaking Abstracts
T. Zenz Chronic Lymphocytic Leukaemia (CLL) Molecular Genetics in Lymphoma - Current Knowledge and New Insights From High-Throughput Technologies
K. Flaherty Melanoma Therapy - Realising the Potential in Targeted Therapy Melanoma Therapy - Realising the Potential in Targeted Therapy
D. Kerr ESMO Award Presentation European Society for Medical Oncology (ESMO) - Awards Session
A. Ribas Combining TKI's in Melanoma: Which Rationale, How and When Melanoma Therapy - Realising the Potential in Targeted Therapy
J. Fitzgibbon A Molecular Portrait of Follicular Lymphoma Molecular Genetics in Lymphoma - Current Knowledge and New Insights From High-Throughput Technologies
N. Bisheva Bladder Cancer Presentation ESMO Clinical Practice Guidelines